Oppenheimer & Co. Inc. Sells 6,917 Shares of Encompass Health Corporation $EHC

Oppenheimer & Co. Inc. lessened its position in Encompass Health Corporation (NYSE:EHC) by 7.0% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 91,497 shares of the company’s stock after selling 6,917 shares during the period. Oppenheimer & Co. Inc. owned 0.09% of Encompass Health worth $11,622,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Tectonic Advisors LLC increased its stake in shares of Encompass Health by 1.6% in the third quarter. Tectonic Advisors LLC now owns 5,337 shares of the company’s stock valued at $678,000 after buying an additional 82 shares during the period. Global Retirement Partners LLC grew its holdings in Encompass Health by 23.0% during the 3rd quarter. Global Retirement Partners LLC now owns 449 shares of the company’s stock worth $57,000 after acquiring an additional 84 shares during the last quarter. EP Wealth Advisors LLC increased its position in Encompass Health by 2.4% in the 2nd quarter. EP Wealth Advisors LLC now owns 3,694 shares of the company’s stock valued at $453,000 after acquiring an additional 88 shares during the period. Natural Investments LLC raised its stake in shares of Encompass Health by 1.2% during the third quarter. Natural Investments LLC now owns 7,808 shares of the company’s stock valued at $991,000 after acquiring an additional 89 shares during the last quarter. Finally, TD Private Client Wealth LLC lifted its holdings in shares of Encompass Health by 1.1% during the third quarter. TD Private Client Wealth LLC now owns 8,216 shares of the company’s stock worth $1,044,000 after purchasing an additional 91 shares during the period. 97.25% of the stock is owned by institutional investors and hedge funds.

Encompass Health Stock Up 0.9%

Encompass Health stock opened at $106.33 on Tuesday. Encompass Health Corporation has a 12-month low of $92.53 and a 12-month high of $127.99. The company has a quick ratio of 1.14, a current ratio of 1.08 and a debt-to-equity ratio of 0.76. The company has a market capitalization of $10.70 billion, a PE ratio of 19.19, a PEG ratio of 1.66 and a beta of 0.73. The firm’s fifty day moving average is $104.09 and its 200 day moving average is $114.49.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Thursday, February 5th. The company reported $1.46 earnings per share for the quarter, beating the consensus estimate of $1.29 by $0.17. The firm had revenue of $3.09 billion for the quarter, compared to analyst estimates of $1.54 billion. Encompass Health had a net margin of 9.54% and a return on equity of 18.20%. The business’s quarterly revenue was up 9.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.17 earnings per share. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. As a group, sell-side analysts predict that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Wall Street Analyst Weigh In

EHC has been the subject of a number of recent research reports. Zacks Research downgraded Encompass Health from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 19th. Raymond James Financial upgraded Encompass Health to a “strong-buy” rating in a research report on Friday, October 31st. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a research report on Sunday, January 18th. Finally, Barclays upped their target price on Encompass Health from $150.00 to $153.00 and gave the company an “overweight” rating in a report on Friday. Two investment analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, Encompass Health has a consensus rating of “Buy” and an average price target of $143.29.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.